Registro:

Referencias:

• Abbass, S.A., Asa, S.L., Ezzat, S., Altered expression of fibroblast growth factor receptors in human pituitary adenomas (1997) J Clin Endocrinol Metab, 82, pp. 1160-1166
• Arnaud, E., Touriol, C., Boutonnet, C., Gensac, M.C., Vagner, S., Prats, H., Prats, A.C., A new 34-kilodalton isoform of human fibroblast growth factor 2 is cap dependently synthesized by using a non-AUG start codon and behaves as a survival factor (1999) Mol Cell Biol, 19, pp. 505-514
• Asa, S.L., Kelly, M.A., Grandy, D.K., Low, M.J., Pituitary lactotroph adenomas develop after prolonged lactotroph hyperplasia in dopamine D2 receptor-deficient mice (1999) Endocrinology, 140, pp. 5348-5355
• Baird, A., Mormede, P., Ying, S.Y., Wehrenberg, W.B., Ueno, N., Ling, N., Guillemin, R., A nonmitogenic pituitary function of fibroblast growth factor: Regulation of thyrotropin and prolactin secretion (1985) Proc Natl Acad Sci USA, 82, pp. 5545-5549
• Bikfalvi, A., Klein, S., Pintucci, G., Rifkin, D.B., Biological roles of fibroblast growth factor-2 (1997) Endocr Rev, 18, pp. 26-45
• Black, E.G., Logan, A., Davis, J.R., Sheppard, M.C., Basic fibroblast growth factor affects DNA synthesis and cell function and activates multiple signalling pathways in rat thyroid FRTL-5 and pituitary GH3 cells (1990) J Endocrinol, 127, pp. 39-46
• Choi, J., Ko, M.K., Kay, E.P., Subcellular localization of the expressed 18 kDa FGF-2 isoform in corneal endothelial cells (2000) Mol Vis, 6, pp. 222-231
• Cristina, C., Diaz-Torga, G., Baldi, A., Gongora, A., Rubinstein, M., Low, M.J., Becu-Villalobos, D., Increased pituitary vascular endothelial growth factor-A in dopaminergic D2 receptor knockout female mice (2005) Endocrinology, 146, pp. 2952-2962
• Cristina, C., Diaz-Torga, G.S., Goya, R.G., Kakar, S.S., Perez-Millan, M.I., Passos, V.Q., Gianella-Neto, D., Becu-Villalobos, D., PTTG expression in different experimental and human prolactinomas in relation to dopaminergic control of lactotropes (2007) Mol Cancer, 6, p. 4
• Cristina, C., García-Tornadú, I., Diaz-Torga, G., Rubinstein, M., Low, M.J., Becu-Villalobos, D., The dopaminergic D2 receptor knockout mouse: An animal model of prolactinoma (2006) Front Horm Res, 35, pp. 50-63
• Delrieu, I., The high molecular weight isoforms of basic fibroblast growth factor (FGF-2): An insight into an intracrine mechanism (2000) FEBS Lett, 468, pp. 6-10
• Diaz-Torga, G., Feierstein, C., Libertun, C., Gelman, D., Kelly, M.A., Low, M.J., Rubinstein, M., Becu-Villalobos, D., Disruption of the D2 dopamine receptor alters GH and IGF-I secretion and causes dwarfism in male mice (2002) Endocrinology, 143, pp. 1270-1279
• Ezzat, S., Smyth, H.S., Ramyar, L., Asa, S.L., Heterogeneous in vivo and in vitro expression of basic fibroblast growth factor by human pituitary adenomas (1995) J Clin Endocrinol Metab, 80, pp. 878-884
• Ezzat, S., Zheng, L., Asa, S.L., Pituitary tumor-derived fibroblast growth factor receptor 4 isoform disrupts neural cell-adhesion molecule/N-cadherin signaling to diminish cell adhesiveness: A mechanism underlying pituitary neoplasia (2004) Mol Endocrinol, 18, pp. 2543-2552
• Ferrara, N., Schweigerer, L., Neufeld, G., Mitchell, R., Gospodarowicz, D., Pituitary follicular cells produce basic fibroblast growth factor (1987) Proc Natl Acad Sci USA, 84, pp. 5773-5777
• Florkiewicz, R.Z., Baird, A., Gonzalez, A.M., Multiple forms of bFGF: Differential nuclear and cell surface localization (1991) Growth Factors, 4, pp. 265-275
• Florkiewicz, R.Z., Majack, R.A., Buechler, R.D., Florkiewicz, E., Quantitative export of FGF-2 occurs through an alternative, energy-dependent, non-ER/Golgi pathway (1995) J Cell Physiol, 162, pp. 388-399
• Fukui, S., Otani, N., Nawashiro, H., Yano, A., Nomura, N., Miyazawa, T., Ohnuki, A., Shima, K., Subcellular localization of basic fibroblast growth factor and fibroblast growth factor receptor 1 in pituitary adenomas (2002) Brain Tumor Pathol, 19, pp. 23-29
• Fumagalli, F., Bedogni, F., Maragnoli, M.E., Gennarelli, M., Perez, J., Racagni, G., Riva, M.A., Dopaminergic D2 receptor activation modulates FGF-2 gene expression in rat prefrontal cortex and hippocampus (2003) J Neurosci Res, 74, pp. 74-80
• Garcia-Tornadu, I., Rubinstein, M., Gaylinn, B.D., Hill, D., Arany, E., Low, M.J., Diaz-Torga, G., Becu-Villalobos, D., GH in the dwarf dopaminergic D2 receptor knockout mouse: Somatotrope population, GH release, and responsiveness to GH-releasing factors and somatostatin (2006) J Endocrinol, 190, pp. 611-619
• Gonzalez, A.M., Logan, A., Ying, W., Lappi, D.A., Berry, M., Baird, A., Fibroblast growth factor in the hypothalamic-pituitary axis: Differential expression of fibroblast growth factor-2 and a high affinity receptor (1994) Endocrinology, 134, pp. 2289-2297
• Gonzalez Iglesias, A., Diaz-Torga, G., Piroli, G., Achaval-Zaia, R., De Nicola, A.F., Libertun, C., Becu-Villalobos, D., Bromocriptine restores Angiotensin II response in pituitary hyperplasia (2000) Mol Cell Endocrinol, 165, pp. 67-74
• Gospodarowicz, D., Cheng, J., Lui, G.M., Baird, A., Bohlen, P., Isolation of brain fibroblast growth factor by heparin-Sepharose affinity chromatography: Identity with pituitary fibroblast growth factor (1984) Proc Natl Acad Sci USA, 81, pp. 6963-6967
• Gospodarowicz, D., Ferrara, N., Schweigerer, L., Neufeld, G., Characterization and biological functions of fibroblast growth factors (1987) Endocr Rev, 8, pp. 95-114
• Graeven, U., Fiedler, W., Karpinski, S., Ergun, S., Kilic, N., Rodeck, U., Schmiegel, W., Hossfeld, D.K., Melanoma-associated expression of vascular endothelial growth factor and its receptors FLT-1 and KDR (1999) J Cancer Res Clin Oncol, 125, pp. 621-629
• Heaney, A.P., Fernando, M., Melmed, S., Functional role of estrogen in pituitary tumor pathogenesis (2002) J Clin Invest, 109, pp. 277-283
• Heaney, A.P., Horwitz, G.A., Wang, Z., Singson, R., Melmed, S., Early involvement of estrogen-induced pituitary tumor transforming gene and fibroblast growth factor expression in prolactinoma pathogenesis (1999) Nat Med, 5, pp. 1317-1321
• Iaccarino, C., Samad, T.A., Mathis, C., Kercret, H., Picetti, R., Borrelli, E., Control of lactotrop proliferation by dopamine: Essential role of signaling through D2 receptors and ERKs (2002) Proc Natl Acad Sci USA, 99, pp. 14530-14535
• Ishikawa, H., Heaney, A.P., Yu, R., Horwitz, G.A., Melmed, S., Human pituitary tumor-transforming gene induces angiogenesis (2001) J Clin Endocrinol Metab, 86, pp. 867-874
• Joy, A., Moffett, J., Neary, K., Mordechai, E., Stachowiak, E.K., Coons, S., Rankin-Shapiro, J., Stachowiak, M.K., Nuclear accumulation of FGF-2 is associated with proliferation of human astrocytes and glioma cells (1997) Oncogene, 14, pp. 171-183
• Kelly, M.A., Rubinstein, M., Asa, S.L., Zhang, G., Saez, C., Bunzow, J.R., Allen, R.G., Low, M.J., Pituitary lactotroph hyperplasia and chronic hyperprolactinemia in dopamine D2 receptor-deficient mice (1997) Neuron, 19, pp. 103-113
• Keresztes, M., Boonstra, J., Import(ance) of growth factors in(to) the nucleus (1999) J Cell Biol, 145, pp. 421-424
• Kuchenbauer, F., Theodoropoulou, M., Hopfner, U., Stalla, J., Renner, U., Tonn, J.C., Low, M.J., Paez-Pereda, M., Laminin inhibits lactotroph proliferation and is reduced in early prolactinoma development (2003) Mol Cell Endocrinol, 207, pp. 13-20
• Larson, G.H., Koos, R.D., Sortino, M.A., Wise, P.M., Acute effect of basic fibroblast growth factor on secretion of prolactin as assessed by the reverse hemolytic plaque assay (1990) Endocrinology, 126, pp. 927-932
• Li, A., Guo, H., Luo, X., Sheng, J., Yang, S., Yin, Y., Zhou, J., Zhou, J., Apomorphine-induced activation of dopamine receptors modulates FGF-2 expression in astrocytic cultures and promotes survival of dopaminergic neurons (2006) FASEB J, 20, pp. 1263-1265
• Li, Y., Koga, M., Kasayama, S., Matsumoto, K., Arita, N., Hayakawa, T., Sato, B., Identification and characterization of high molecular weight forms of basic fibroblast growth factor in human pituitary adenomas (1992) J Clin Endocrinol Metab, 75, pp. 1436-1441
• Marin, F., Boya, J., Immunocytochemical localization of basic fibroblast growth factor in the human pituitary gland (1995) Neuroendocrinology, 62, pp. 523-529
• McCabe, C.J., Khaira, J.S., Boelaert, K., Heaney, A.P., Tannahill, L.A., Hussain, S., Mitchell, R., Gittoes, N.J., Expression of pituitary tumour transforming gene (PTTG) and fibroblast growth factor-2 (FGF-2) in human pituitary adenomas: Relationships to clinical tumour behaviour (2003) Clin Endocrinol (Oxf), 58, pp. 141-150
• Meloche, S., Seuwen, K., Pages, G., Pouyssegur, J., Biphasic and synergistic activation of p44mapk (ERK1) by growth factors: Correlation between late phase activation and mitogenicity (1992) Mol Endocrinol, 6, pp. 845-854
• Mormede, P., Baird, A., Estrogens, cyclic adenosine 3-′,5′-monophosphate, and phorbol esters modulate the prolactin response of GH3 cells to basic fibroblast growth factor (1988) Endocrinology, 122, pp. 2265-2271
• Moscatelli, D., High and low affinity binding sites for basic fibroblast growth factor on cultured cells: Absence of a role for low affinity binding in the stimulation of plasminogen activator production by bovine capillary endothelial cells (1987) J Cell Physiol, 131, pp. 123-130
• Moscatelli, D., Autocrine downregulation of fibroblast growth factor receptors in F9 teratocarcinoma cells (1994) J Cell Physiol, 160, pp. 555-562
• Mukdsi, J.H., De Paul, A.L., Petiti, J.P., Gutierrez, S., Aoki, A., Torres, A.I., Pattern of FGF-2 isoform expression correlated with its biological action in experimental prolactinomas (2006) Acta Neuropathol (Berl), 112, pp. 491-501
• Okada-Ban, M., Thiery, J.P., Jouanneau, J., Fibroblast growth factor-2 (2000) Int J Biochem Cell Biol, 32, pp. 263-267
• Piroli, G., Torres, A., Grillo, C., Lux-Lantos, V., Aoki, A., De Nicola, A.F., Mechanisms in progestin antagonism of pituitary tumorigenesis (1998) J Steroid Biochem Mol Biol, 64, pp. 59-67
• Presta, M., Dell'Era, P., Mitola, S., Moroni, E., Ronca, R., Rusnati, M., Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis (2005) Cytokine Growth Factor Rev, 16, pp. 159-178
• Renko, M., Quarto, N., Morimoto, T., Rifkin, D.B., Nuclear and cytoplasmic localization of different basic fibroblast growth factor species (1990) J Cell Physiol, 144, pp. 108-114
• Roceri, M., Molteni, R., Fumagalli, F., Racagni, G., Gennarelli, M., Corsini, G., Maggio, R., Riva, M., Stimulatory role of dopamine on fibroblast growth factor-2 expression in rat striatum (2001) J Neurochem, 76, pp. 990-997
• Saiardi, A., Bozzi, Y., Baik, J.H., Borrelli, E., Antiproliferative role of dopamine: Loss of D2 receptors causes hormonal dysfunction and pituitary hyperplasia (1997) Neuron, 19, pp. 115-126
• Schechter, J., Weiner, R., Changes in basic fibroblast growth factor coincident with estradiol-induced hyperplasia of the anterior pituitaries of Fischer 344 and Sprague-Dawley rats (1991) Endocrinology, 129, pp. 2400-2408
• Silverlight, J.J., Prysor-Jones, R.A., Jenkins, J.S., Basic fibroblast growth factor in human pituitary tumors (1990) Clin Endocrinol (Oxf), 32, pp. 669-676
• Straume, O., Akslen, L.A., Importance of vascular phenotype by basic fibroblast growth factor, and influence of the angiogenic factors basic fibroblast growth factor/fibroblast growth factor receptor-1 and ephrin-A1/ EphA2 on melanoma progression (2002) Am J Pathol, 160, pp. 1009-1019
• Strauss, O., Mergler, S., Wiederholt, M., Regulation of L-type calcium channels by protein tyrosine kinase and protein kinase C in cultured rat and human retinal pigment epithelial cells (1997) FASEB J, 11, pp. 859-867
• Sulpice, E., Bryckaert, M., Lacour, J., Contreres, J.O., Tobelem, G., Platelet factor 4 inhibits FGF2-induced endothelial cell proliferation via the extracellular signal-regulated kinase pathway but not by the phosphatidyl-inositol 3-kinase pathway (2002) Blood, 100, pp. 3087-3094
• Tfelt-Hansen, J., Kanuparthi, D., Chattopadhyay, N., The emerging role of pituitary tumor transforming gene in tumorigenesis (2006) Clin Med Res, 4, pp. 130-137
• Tooyama, I., Kawamata, T., Walker, D., Yamada, T., Hanai, K., Kimura, H., Iwane, M., McGeer, P.L., Loss of basic fibroblast growth factor in substantia nigra neurons in Parkinson's disease (1993) Neurology, 43, pp. 372-376
• Zhang, X., Horwitz, G.A., Prezant, T.R., Valentini, A., Nakashima, M., Bronstein, M.D., Melmed, S., Structure, expression, and function of human pituitary tumor-transforming gene (PTTG) (1999) Mol Endocrinol, 13, pp. 156-166

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------